Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;109(2):182-8.
doi: 10.1590/0074-0276130344. Epub 2014 Mar 5.

Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil

Affiliations

Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil

Sérgio Ricardo Fernandes Araújo et al. Mem Inst Oswaldo Cruz. 2014 Apr.

Abstract

Leprosy remains prevalent in Brazil. ErbB2 is a receptor for leprosy bacilli entering Schwann cells, which mediates Mycobacterium leprae-induced demyelination and the ERBB2 gene lies within a leprosy susceptibility locus on chromosome 17q11-q21. To determine whether polymorphisms at the ERBB2 locus contribute to this linkage peak, three haplotype tagging single nucleotide polymorphisms (tag-SNPs) (rs2517956, rs2952156, rs1058808) were genotyped in 72 families (208 cases; 372 individuals) from the state of Pará (PA). All three tag-SNPs were associated with leprosy per se [best SNP rs2517959 odds ratio (OR) = 2.22; 95% confidence interval (CI) 1.37-3.59; p = 0.001]. Lepromatous (LL) (OR = 3.25; 95% CI 1.37-7.70; p = 0.007) and tuberculoid (TT) (OR = 1.79; 95% CI 1.04-3.05; p = 0.034) leprosy both contributed to the association, which is consistent with the previous linkage to chromosome 17q11-q21 in the population from PA and supports the functional role of ErbB2 in disease pathogenesis. To attempt to replicate these findings, six SNPs (rs2517955, rs2517956, rs1810132, rs2952156, rs1801200, rs1058808) were genotyped in a population-based sample of 570 leprosy cases and 370 controls from the state of Rio Grande do Norte (RN) and the results were analysed using logistic regression analysis. However, none of the associations were replicated in the RN sample, whether analysed for leprosy per se, LL leprosy, TT leprosy, erythema nodosum leprosum or reversal reaction conditions. The role of polymorphisms at ERBB2 in controlling susceptibility to leprosy in Brazil therefore remains unclear.

PubMed Disclaimer

References

    1. Beck-Bleumink M, Berhe D. Ocurrence of reactions, their diagnosis and management in leprosy patient treated with multidrug therapy. Experience in the leprosy control programmer of the all Africa leprosy and reabilation Training center (ALERT) in Ethiopia. Int J Lepr. 1992;60:173–184. - PubMed
    1. Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages and the innate immune response: does common variation matter? Immunol Rev. 2007;219:167–186. - PMC - PubMed
    1. Blackwell JM, Black GF, Peacock CS, Miller EN, Sibthorpe D, Gnananandha D, Shaw JJ, Silveira F, Lins-Lainson Z, Ramos F, Collins A, Shaw M-A. Immunogenetics of leishmanial and mycobacterial infections: the Belém family study. Philos Trans R Soc Lond B Biol Sci. 1997;352:1331–1345. - PMC - PubMed
    1. Cartel JL, Spiegel A, Ngoc LN, Moulia-Pelat JP, Martin PM, Grosset JH. Leprosy in French Polynesia. The possible impact of multidrug therapy on epidemiological trends. Lepr Rev. 1992;63:223–230. - PubMed
    1. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620. - PubMed

Publication types

MeSH terms